Eyewash Station Additive Concentrate
- Product NDC
- 65785-034
- 11-digit product format
- 657850034
- Labeler code
- 65785
- Product ID
- 65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Chlorhexidine gluconate and Propylene Glycol
- Dosage form
- LIQUID
- Route
- OPHTHALMIC
- Labeler
- Niagara Pharmaceuticals Inc.
- Application
- M018
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2011-11-15
- Substance
- CHLORHEXIDINE GLUCONATE; PROPYLENE GLYCOL
- Active strength
- 145.6; 280 kg/2800L; kg/2800L
- Pharmacologic classes
- Decreased Cell Wall Integrity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 65785-034 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… | ||
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 65785-034 | 65785-034-01 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Eyewash Station Additive Concentrate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CHLORHEXIDINE GLUCONATE | 145.6 kg/2800L |
| PROPYLENE GLYCOL | 280 kg/2800L |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| MOR84MUD8E | Internal UNII lookup |
| 6DC9Q167V3 | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362a6b6d-862d-4322-87a8-5b3a07fbe174 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 65785-034-01 | 2023-02-21 | C162847 | 48780-1 | f386c64a-201f-0266-e053-dadaa90a7c1a | EYEWASH STATION ADDITIVE CONCENTRATE |
| 65785-034-01 | 2023-01-30 | C162847 | 48780-1 | f386c64a-201f-0266-e053-dadaa90a7c1a | EYEWASH STATION ADDITIVE CONCENTRATE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65785-034-01 | Eyewash Station Additive Concentrate | 0.236 L in 1 BOTTLE, UNIT-DOSE | LIQUID | 0.236 | 8 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Chlorhexidine gluconate | ACTIVE INGREDIENT | MOR84MUD8E | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 | |
| Propylene Glycol | ACTIVE INGREDIENT | 6DC9Q167V3 | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 | |
| Chlorhexidine | ACTIVE MOIETY | R4KO0DY52L | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 | |
| Propylene Glycol | ACTIVE MOIETY | 6DC9Q167V3 | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65785-034 | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20250115_362a6b6d-862d-4322-87a8-5b3a07fbe174.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eye Wash | WATER | Hubei Changjian Medical Products Co., Ltd. | d57e1c5b-1edc-4a94-88bc-f9ecf347b7ea | 2024-10-11 | Warnings | M018 |
| Capasil Pain Relieving | MENTHOL, METHYL SALICYLATE | PureTek Corporation | b1a8e78c-57f0-1f3e-e053-2995a90acbd5 | 2024-10-01 | Warnings | M018 |
| Mencylate Pain Relieving | MENTHOL, METHYL SALICYLATE | PureTek Corporation | f824de86-9492-2e6b-e053-6294a90a6f2a | 2024-10-01 | Warnings | M018 |
| Advanced Eye Relief/ Redness Maximum Relief | NAPHAZOLINE HYDROCHLORIDE AND HYPROMELLOSE | Bausch & Lomb Incorporated | 3c11285a-7e86-4b47-b1ee-e7d59858087d | 2024-09-25 | Warnings | M018 |
| Muro 128 | SODIUM CHLORIDE | Bausch & Lomb Incorporated | cc3d5bc8-9d3c-4c65-9e43-707a2db4081a | 2024-09-25 | Warnings | M018 |
| Muro 128 | SODIUM CHLORIDE | Bausch & Lomb Incorporated | 93fafa27-5031-4d95-b4b8-5574b7204ae2 | 2024-09-25 | Warnings | M018 |
| Muro 128 | SODIUM CHLORIDE | Bausch & Lomb Incorporated | 454f337e-d897-46de-ab05-1c543a33061c | 2024-09-25 | Warnings | M018 |
| PURPOSE | OCTINOXATE, OCTISALATE AND OXYBENZONE | Bausch & Lomb Incorporated | a1e14135-b8da-4cee-8c5b-1893572f4de4 | 2024-09-25 | Warnings | M018 |
| Soothe Night Time | WHITE PETROLATUM MINERAL OIL | Bausch & Lomb Incorporated | 638d3c3f-9960-43da-956e-0e28c77f533e | 2024-09-24 | Warnings | M018 |
| blink tears | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | 10fcf407-6eaf-4730-9ed0-9b7715cf5701 | 2024-09-20 | Warnings | M018 |
| Soothe XP Preservative Free | LIGHT MINERAL OIL AND MINERAL OIL | Bausch & Lomb Incorporated | b254d885-6d49-4c95-b6be-cfdad49c85e6 | 2024-09-20 | Warnings | M018 |
| blink gel tears | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | 6f7e06c3-204d-459a-af8f-c46be9ad0e8d | 2024-09-20 | Warnings | M018 |
| Soothe XP | LIGHT MINERAL OIL AND MINERAL OIL | Bausch & Lomb Incorporated | c0f053da-8d22-433e-a36e-79cf15ad387f | 2024-09-20 | Warnings | M018 |
| Soothe | GLYCERIN AND PROPYLENE GLYCOL | Bausch & Lomb Incorporated | fef002ea-c4bd-4486-a42e-1bbd9d73d28d | 2024-09-20 | Warnings | M018 |
| Leader Preservative-Free Ultra Lubricating Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Cardinal Health | 2a2aa620-ca63-4698-88fd-fc263b8fa0d1 | 2024-09-07 | Warnings | M018 |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | ad42a7e3-84ea-390d-e053-2a95a90a3a32 | 2024-06-14 | Warnings | M018 |
| Artificial Tears | POLYVINYL ALCOHOL, POVIDONE | NuCare Pharmaceuticals,Inc. | 9c1c4911-908e-3c3c-e053-2995a90abcfc | 2024-06-14 | Warnings | M018 |
| Eyes Alive Eye Wash | WATER | RIVIERA PHARMA INC | 081079f4-1c06-4054-b771-00fedaa666f6 | 2024-06-05 | Warnings | M018 |
| Eyes Alive Lubricating | CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED | RIVIERA PHARMA INC | b6966691-6884-438c-9f89-5924089226e1 | 2024-05-31 | Warnings | M018 |
| Eye Wash | WATER | M-star (Hubei) Health&Care Products Co., Ltd. | 71706039-e250-4f08-9687-71b2928c4e46 | 2024-04-01 | Warnings | M018 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 65785-034-01 | 65785003401 | .236 L in 1 BOTTLE, UNIT-DOSE (65785-034-01) | 2011-11-15 | 0000-00-00 | No | No | Current |